US Stocks
/
Hemab Therapeutics Holdings, Inc. Share Price

Hemab Therapeutics Holdings, Inc. Share Price

NASDAQ: COAG
$31.60
+$0.40 (1.28%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Hemab Therapeutics Holdings, Inc. Stock Performance

Open
$30.18
Prev. Close
$31.20
Circuit Range
N/A
Day Range
$29.98 - $33.93
Year Range
$23.50 - $54.94
Volume
37,247
Average Traded
$31.94

Hemab Therapeutics Holdings, Inc. Share Price Today

As of 12 October 2026, Hemab Therapeutics Holdings, Inc.'s share price is $31.60. The stock opened at $30.18, compared to its previous close of $31.20. During today's trading session, Hemab Therapeutics Holdings, Inc.'s share price traded between $29.98 and $33.93, with an average price of $31.95. Over the past 52 weeks, the stock has recorded a high of $54.94 and a low of $23.50. In terms of performance, Hemab Therapeutics Holdings, Inc.'s share price has risen by 11.31% over the last six months and is up 11.31% on a year-on-year basis.

Hemab Therapeutics Holdings, Inc. Share Price Chart

$29.98$33.93
L
Show Current Price
H

Hemab Therapeutics Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Hemab Therapeutics Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026
Revenue$0.00
Net Profit-$24.15
Net Profit MarginN/A
Income ChangeN/A

About Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Hemab Therapeutics Holdings, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$30.64
$31.65
+2.13%
Sep 2026
$44.85
$30.99
-37.34%
Aug 2026
$46.71
$49.46
+4.61%
Jul 2026
$34.86
$47.28
+29.11%
Jun 2026
$27.53
$36.62
+28.99%
May 2026
$27.04
$28.39
N/A

COAG Share Price FAQs

What is Hemab Therapeutics Holdings, Inc. share price today?

chevron-up
Hemab Therapeutics Holdings, Inc. share price today is $31.60 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Hemab Therapeutics Holdings, Inc. stock?

chevron-up
The 52 week high of Hemab Therapeutics Holdings, Inc. stock is $54.94, while the 52 week low is $23.50 as of 10 Oct '26.

What is COAG's net income for the last quarter?

chevron-up
COAG's net income for the last quarter is -24.15B USD.

What is the 5 year returns of COAG?

chevron-up
The 5 year returns of COAG is 11.31% as on 10 Oct '26.

What is the high & low stock price of COAG today?

chevron-up
COAG stock price hit a high of $33.93 and low of $29.98 as of 10 Oct '26.

Can I buy COAG shares in India?

chevron-up
Yes. You can buy COAG in India by opening an international trading account.